Events Archives - Page 107 of 128

1 minute read

Intellia Therapeutics To Present Updated Interim Clinical Data From Ongoing Phase 1/2 Study Of NTLA-2002 For The Treatment Of Hereditary Angioedema At The 2022 ACAAI Annual Scientific Meeting

October 31, 7:32 AM

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced that an abstract

NTLA

2 minute read

Political Ad Spending For Midterms May Shatter Records: Here Are Some Winners And Losers

By Robert Kuczmarski

October 30, 3:37 PM

The 2022 midterm elections are setting up to be the highest-spending political advertising cycle of all time. AdImpact forecasts that upwards of $9.7 billion will be spent on political advertising, revised from $8.9 billion projected in July 2021.

DIS

2 minute read

What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out

By Lara Goldstein

October 28, 12:23 PM

Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e.

FTHWF

2 minute read

5 Philadelphia Fintech Companies To Watch: Venmo, InstaMed And More

By Philip Lloyd

October 28, 12:17 PM

Fintech has not only changed the way we do business, but how we lead our daily lives. Millions of times every day, Americans use fintech apps like Venmo and Zelle to send money straight from their phones, or Paypal and TorFx, to conduct business transactions.

PYPL

2 minute read

Looking For A Short Squeeze Candidate: 2 Small Caps With Soaring Yields And Are Heavily Shorted

By Robert Kuczmarski

October 26, 3:50 PM

When investing in heavily shorted stocks, it is important to know that floating shares are the number of shares available for trading on a particular stock.

BGFV

1 minute read

Events
News

Wallbox Tweets ‘Get ready, Wallboxers! Something HUGE is happening tomorrow. ‘

By Benzinga Newsdesk

October 26, 12:19 PM

https://twitter.com/wallboxchargers/status/1585297639658037248

WBX

1 minute read

Aileron Therapeutics Presents Results From Phase 1 Study In Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest On Bone Marrow Stem Cells And Hair Follicles At EORTC-NCI-AACR International Conference

By Benzinga Newsdesk

October 26, 6:07 AM

p53-mediated cell cycle arrest results demonstrate potential of ALRN-6924 to prevent chemotherapy-induced neutropenia, thrombocytopenia, and anemia, as well as chemotherapy-induced alopecia (hair loss) Study showed

ALRN

4 minute read

Atara Biotherapeutics Presents New MRI And Updated Open-Label Extension Data From Phase 1 Study Of ATA188 In Progressive Multiple Sclerosis At ECTRIMS 2022 October 26-28

By Benzinga Newsdesk

October 26, 2:07 AM

Sustained Improvement Observed in ATA188 Treated Patients Achieving Confirmed Disability Improvement (CDI) in Open Label Extension (OLE) with up to 46 Months Follow up Patients Treated with ATA188 that Achieved CDI

ATRA